Answers are grounded in this paper and cite their sources.
Translational studies advance understanding of breast cancer biology and management implications.
Every year, the San Antonio Breast Cancer Symposium (SABCS) serves as the major catalyst for new developments across all fronts and disciplines in breast cancer, from prevention and early detection to the pathophysiology and management of metastatic breast cancer.Although novel agents and practicechanging clinical trials receive the lion's share of the audiences' attention, several translational studies are reported that enhance significantly our understanding of breast cancer.In highlighting some of the most impactful translational presentations, we will divide them across 5 major thematic categories: dissecting the biology of residual disease, tumor evolution, circulating tumor DNA, precision medicine in early-stage and metastatic breast cancer.
No takes yet. Share an insight, caveat, or question.
Zhukovsky et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: